TY - JOUR
T1 - Microneedle coating methods
T2 - A review with a perspective
AU - Ingrole, Rohan S.J.
AU - Gill, Harvinder Singh
N1 - Funding Information:
This publication was supported by the National Institute of Allergy and Infectious Diseases National Institutes of Health [Award Numbers R01AI135197 and R01AI121322 to H.S.G.]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Financial Disclosures: HSG is a coinventor on a patent related to coated microneedles and has stock ownership in a startup company called Moonlight Therapeutics that is developing microneedles for food allergy immunotherapy. This conflict of interest has been disclosed and is being managed by Texas Tech University. No financial support was provided by Moonlight Therapeutics for this work.
Funding Information:
This publication was supported by the National Institute of Allergy and Infectious Diseases National Institutes of Health [Award Numbers R01AI135197 and R01AI121322 to H.S.G.]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Financial Disclosures: HSG is a coinventor on a patent related to coated microneedles and has stock ownership in a startup company called Moonlight Therapeutics that is developing microneedles for food allergy immunotherapy. This conflict of interest has been disclosed and is being managed by Texas Tech University. No financial support was provided by Moonlight Therapeutics for this work. https://doi.org/10.1124/jpet.119.258707.
Publisher Copyright:
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2019
Y1 - 2019
N2 - A coated microneedle array comprises sharp micrometer-sized needle shafts attached to a base substrate and coated with a drug on their surfaces. Coated microneedles are under investigation for drug delivery into the skin and other tissues, and a broad assortment of active materials, including small molecules, peptides, proteins, deoxyribonucleic acids, and viruses, have been coated onto microneedles. To coat the microneedles, different methods have been developed. Some coating methods achieve selective coating of just the microneedle shafts, whereas other methods coat not only microneedle shafts but also the array base substrate. Selective coating of just the microneedle shafts is more desirable since it provides control over drug dosage, prevents drug waste, and offers high delivery efficiency. Different excipients are added to the coating liquid to modulate its viscosity and surface tension in order to achieve uniform coatings on microneedles. Coated microneedles have been used in a broad range of biomedical applications. To highlight these different applications, a table summarizing the different active materials and the amounts coated on microneedles is provided. We also discuss factors that should be considered when deciding suitability of coated microneedles for new-drug delivery applications. In recent years, many coated microneedles have been investigated in human clinical trials, and there is now a strong effort to bring the first coated microneedle-based product to market.
AB - A coated microneedle array comprises sharp micrometer-sized needle shafts attached to a base substrate and coated with a drug on their surfaces. Coated microneedles are under investigation for drug delivery into the skin and other tissues, and a broad assortment of active materials, including small molecules, peptides, proteins, deoxyribonucleic acids, and viruses, have been coated onto microneedles. To coat the microneedles, different methods have been developed. Some coating methods achieve selective coating of just the microneedle shafts, whereas other methods coat not only microneedle shafts but also the array base substrate. Selective coating of just the microneedle shafts is more desirable since it provides control over drug dosage, prevents drug waste, and offers high delivery efficiency. Different excipients are added to the coating liquid to modulate its viscosity and surface tension in order to achieve uniform coatings on microneedles. Coated microneedles have been used in a broad range of biomedical applications. To highlight these different applications, a table summarizing the different active materials and the amounts coated on microneedles is provided. We also discuss factors that should be considered when deciding suitability of coated microneedles for new-drug delivery applications. In recent years, many coated microneedles have been investigated in human clinical trials, and there is now a strong effort to bring the first coated microneedle-based product to market.
UR - http://www.scopus.com/inward/record.url?scp=85071711305&partnerID=8YFLogxK
U2 - 10.1124/jpet.119.258707
DO - 10.1124/jpet.119.258707
M3 - Review article
C2 - 31175217
AN - SCOPUS:85071711305
SN - 0022-3565
VL - 370
SP - 555
EP - 569
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 3
ER -